Skip to main content
. 2021 Sep 20;118(39):e2026676118. doi: 10.1073/pnas.2026676118

Fig. 1.

Fig. 1.

CONSORT diagram for the CPASS trial. Seventy-two individuals were adaptively randomized to receive CPASS therapy acute (≤30 d poststroke), subacute (2 to 3 mo), chronic (≥6 mo poststroke), or the control group.